Table 4 Visual and Anatomical Outcomes after 18 Months of Treatment with Aflibercept for Central Retinal Vein Occlusion, Stratified with Respect of Injection Interval at 18 Months
Injection interval ″ 8 weeks | Injection interval ≥ 10 weeks | P value | |
|---|---|---|---|
Absolute visual acuity (ETDRS letters) | 75.8 ± 11.5 | 73.8 ± 9.3 | 0.70 |
Mean gain in visual acuity (ETDRS letters) | 22.8 ± 20.3 | 21.2 ± 11.6 | 0.85 |
Gain in visual acuity by ≥15 ETDRS letters | 5 of 8 (63%) | 7 of 9 (78%) | 0.62 |
Absolute central macular thickness (μm) | 262 [242 to 285] | 272 [275 to 296] | 0.54 |
Mean reduction in central macular thickness (μm) | − 552 ± 325 | − 518 ± 296 | 0.83 |